Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Belgian firm boosts biomarkers

October 16, 2006 | A version of this story appeared in Volume 84, Issue 42

The Belgian biotechnology firm Peakadilly has been awarded a $2.2 million grant by the government of Belgian state Flanders to accelerate the development of its diagnostic and pharmacodiagnostic biomarker discovery platform. The grant was awarded by IWT-Flanders, the Institute for the Promotion of Innovation by Science & Technology in Flanders, an organization that provides financial support to Flemish companies, research institutes, and individuals in R&D. According to Koen Kas, founder and chief scientific officer of Peakadilly, the company's goal "is to deliver proof of concept for the development of the first high-throughput mass spectrometry-based serum protein-profiling assay as we progress in the development of next-generation molecular diagnostics."

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.